MXPA04002247A - Metodo para la preparacion de hexahidro-furo[2,3-b]furan-3-ol. - Google Patents
Metodo para la preparacion de hexahidro-furo[2,3-b]furan-3-ol.Info
- Publication number
- MXPA04002247A MXPA04002247A MXPA04002247A MXPA04002247A MXPA04002247A MX PA04002247 A MXPA04002247 A MX PA04002247A MX PA04002247 A MXPA04002247 A MX PA04002247A MX PA04002247 A MXPA04002247 A MX PA04002247A MX PA04002247 A MXPA04002247 A MX PA04002247A
- Authority
- MX
- Mexico
- Prior art keywords
- furo
- hexahydro
- furan
- preparation
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
La presente invencion se relaciona con un metodo para la preparacion de hexahidro-furo[2,3-b]furan-3-ol, asi como con novedosos intermediarios para usar en dicho metodo; mas especificamente, la invencion se relaciona con un metodo estereoselectivo para la preparacion de hexahidro-furo[2,3-b]furan-3-ol, y con un metodo que se presta para la elaboracion en escala industrial.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01203416 | 2001-09-10 | ||
PCT/EP2002/010062 WO2003022853A1 (en) | 2001-09-10 | 2002-09-06 | Method for the preparation of hexahydro-furo[2,3-b]furan-3-ol |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04002247A true MXPA04002247A (es) | 2005-09-07 |
Family
ID=8180908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04002247A MXPA04002247A (es) | 2001-09-10 | 2002-09-06 | Metodo para la preparacion de hexahidro-furo[2,3-b]furan-3-ol. |
Country Status (28)
Country | Link |
---|---|
US (1) | US7126015B2 (es) |
EP (1) | EP1448567B1 (es) |
JP (1) | JP4521185B2 (es) |
KR (1) | KR100894673B1 (es) |
CN (2) | CN100519561C (es) |
AP (1) | AP1758A (es) |
AR (1) | AR036501A1 (es) |
AT (1) | ATE453648T1 (es) |
AU (1) | AU2002333809C1 (es) |
BR (1) | BRPI0212341B8 (es) |
CA (1) | CA2459168C (es) |
CY (1) | CY1109974T1 (es) |
DE (1) | DE60234952D1 (es) |
DK (1) | DK1448567T3 (es) |
EA (1) | EA010883B1 (es) |
ES (1) | ES2338538T3 (es) |
HK (1) | HK1068887A1 (es) |
HR (1) | HRP20040320B1 (es) |
HU (1) | HU229505B1 (es) |
IL (2) | IL160166A0 (es) |
MX (1) | MXPA04002247A (es) |
NO (1) | NO328934B1 (es) |
NZ (1) | NZ531641A (es) |
PL (1) | PL224030B1 (es) |
PT (1) | PT1448567E (es) |
SI (1) | SI21463B (es) |
WO (1) | WO2003022853A1 (es) |
ZA (1) | ZA200401501B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1532127E (pt) * | 2002-06-27 | 2007-01-31 | Smithkline Beecham Corp | Preparação de estereoisómeros de ( 3alfa, 3alfa/beta, 6alfa/beta )hexa-hidrofuro ( 2,3-b ) furan-3-ol |
AU2003275675A1 (en) * | 2002-12-27 | 2004-07-29 | Sumitomo Chemical Company, Limited | Process for producing hexahydrofurofuranol derivative, intermediate thereof and process for producing the same |
ME01059B (me) | 2003-12-23 | 2012-10-20 | Janssen Sciences Ireland Uc | Proces za pripremanje (3r,3as,6ar)-heksahidrofuro [2,3-b] furan-3-il (1s,2r)-3-[[(4-aminofenil) sulfonil] (izobutil) amino]-1-benzil-2- hidroksipropilkarbamata |
TWI383975B (zh) * | 2004-03-31 | 2013-02-01 | Tibotec Pharm Ltd | 製備(3R,3aS,6aR)六氫-呋喃并〔2,3-b〕呋喃-3-醇之方法 |
JP5549898B2 (ja) * | 2006-03-31 | 2014-07-16 | 独立行政法人産業技術総合研究所 | 5−ヒドロキシメチル−2−フルフラールの製造法 |
CN101541775B (zh) * | 2006-11-09 | 2011-12-28 | 泰博特克药品有限公司 | 六氢呋喃并[2,3-b]呋喃-3-醇的制备方法 |
CN101024646B (zh) * | 2007-02-06 | 2010-07-14 | 启东东岳药业有限公司 | 4-甲氧基呋喃并呋喃-2-酮的纯化方法 |
BRPI0810609A2 (pt) | 2007-04-27 | 2014-10-21 | Tibotec Pharm Ltd | Métodos para a preparação de derivados de n-isobutil-n-(2-hidróxi-a-amino-4-fenilbutil)-p-nitrobe nzenossulfonilamida |
US8592487B2 (en) | 2007-10-26 | 2013-11-26 | Concert Pharmaceuticals, Inc. | Deuterated darunavir |
TWI482775B (zh) | 2008-09-01 | 2015-05-01 | Tibotec Pharm Ltd | 用於製備(3r,3as,6ar)-六氫呋喃并〔2,3-b〕呋喃-3-基(1s,2r)-3-〔〔(4-胺基苯基)磺醯基〕(異丁基)胺基〕-1-苯甲基-2-羥基丙基胺基甲酸酯之方法 |
US20110257111A1 (en) * | 2008-10-24 | 2011-10-20 | Harbeson Scott L | Hydroxyethlamino Sulfonamide Derivatives |
US8921415B2 (en) | 2009-01-29 | 2014-12-30 | Mapi Pharma Ltd. | Polymorphs of darunavir |
BR112012009956A2 (pt) | 2009-10-30 | 2015-09-29 | Lupin Ltd | um novo processo para a preparação de darunavir e etanolato darunavir de tamanho de partícula. |
PL2528923T3 (pl) | 2010-01-28 | 2015-01-30 | Mapi Pharma Ltd | Sposób wytwarzania darunawiru i pochodnych darunawiru |
US8841467B2 (en) | 2010-11-23 | 2014-09-23 | Mylan Laboratories Limited | Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-ol |
US8802724B2 (en) | 2010-11-30 | 2014-08-12 | Purdue Research Foundation | Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans |
ES2848216T3 (es) | 2012-07-24 | 2021-08-05 | Laurus Labs Ltd | Un proceso para la preparación de Darunavir |
JPWO2014024898A1 (ja) * | 2012-08-09 | 2016-07-25 | 住友化学株式会社 | ヘキサヒドロフロフラノール誘導体の製造方法 |
CN103864813B (zh) * | 2012-12-18 | 2017-02-22 | 上海迪赛诺化学制药有限公司 | 一种合成六氢呋喃并[2,3‑b]呋喃‑3‑醇及其对映体的方法 |
US10633390B2 (en) * | 2015-06-25 | 2020-04-28 | Msn Laboratories Private Limited | Process for the preparation of [(1S,2R)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3R,3AS,6AR)hexahydro furo [2,3-B]furan-3-YL ester and its amorphous form |
WO2017041228A1 (zh) * | 2015-09-08 | 2017-03-16 | 浙江九洲药业股份有限公司 | 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法 |
CN110423228B (zh) * | 2016-02-05 | 2023-01-10 | 成都博腾药业有限公司 | 一种制备地瑞那韦中间体的方法 |
EP3532478B1 (en) | 2016-10-27 | 2021-05-26 | Gilead Sciences, Inc. | Crystalline form of darunavir free base |
CN106928248B (zh) * | 2017-02-04 | 2019-01-04 | 青岛科技大学 | 一种制备(3R,3aS,6aR)六氢呋喃并[2,3-b]呋喃-3-醇的方法 |
CN110272398B (zh) | 2018-03-16 | 2022-11-29 | 江苏瑞科医药科技有限公司 | 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法 |
CN114853774A (zh) * | 2022-06-24 | 2022-08-05 | 盐城迪赛诺制药有限公司 | 一种达卢那韦关键中间体的制备方法 |
CN115557964A (zh) * | 2022-10-18 | 2023-01-03 | 启东东岳药业有限公司 | 一种药物化合物的制备方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4325970A (en) * | 1980-10-09 | 1982-04-20 | Hoffmann-La Roche Inc. | 15-Acetyl-prostaglandins |
NZ224497A (en) * | 1987-05-18 | 1990-04-26 | Janssen Pharmaceutica Nv | Pharmaceutical composition comprising flunarizine |
US5281420A (en) * | 1992-05-19 | 1994-01-25 | The Procter & Gamble Company | Solid dispersion compositions of tebufelone |
AU6828894A (en) * | 1993-05-14 | 1994-12-12 | Merck & Co., Inc. | Hiv protease inhibitors |
DE69415326T2 (de) | 1993-08-24 | 1999-06-02 | Searle & Co | Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen |
RU2089545C1 (ru) * | 1994-09-28 | 1997-09-10 | Ярославский государственный технический университет | Способ получения 2-метил-2-этил-1,3-диоксолан-4-ил-метилметакрилата |
DE19510566A1 (de) * | 1995-03-23 | 1996-09-26 | Kali Chemie Pharma Gmbh | Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE19638020A1 (de) * | 1996-09-18 | 1998-03-19 | Solvay Pharm Gmbh | Die gastrointestinale Durchblutung fördernde Arzneimittel |
RU2211047C2 (ru) * | 1997-01-30 | 2003-08-27 | Новартис Аг | Желатиновые капсулы с твердым покрытием, включающие фармацевтические композиции, практически не содержащие масел |
WO1999067254A2 (en) * | 1998-06-23 | 1999-12-29 | The United States Of America Represented By The Secretary, Department Of Health And Human Services | Multi-drug resistant retroviral protease inhibitors and use thereof |
CA2872424C (en) | 1998-06-23 | 2017-03-07 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Bisfuran derivatives useful in preventing the emergence of multidrug resistant hiv strains and treatment of hiv |
KR100336090B1 (ko) * | 1998-06-27 | 2002-05-27 | 윤승원 | 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제 |
DE19906310A1 (de) * | 1999-02-16 | 2000-08-17 | Solvay Pharm Gmbh | Arzneimittel zur Behandlung von Bluthochdruck |
DE19932555A1 (de) * | 1999-07-13 | 2001-01-18 | Solvay Pharm Gmbh | Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen |
HU228938B1 (hu) * | 1999-10-06 | 2013-06-28 | Us Government | Hexahidrofuro[2,3-b]furán-3-il-N-{3-(1,3-benzodioxol-5-il-szulfonil)-(izobutil)-amino-1-benzil-2- -(hidroxi-propil)}-karbamát mint retrovírus proteáz gátló |
-
2002
- 2002-09-06 BR BRPI0212341A patent/BRPI0212341B8/pt not_active IP Right Cessation
- 2002-09-06 EP EP02797968A patent/EP1448567B1/en not_active Expired - Lifetime
- 2002-09-06 ES ES02797968T patent/ES2338538T3/es not_active Expired - Lifetime
- 2002-09-06 JP JP2003526927A patent/JP4521185B2/ja not_active Expired - Lifetime
- 2002-09-06 PT PT02797968T patent/PT1448567E/pt unknown
- 2002-09-06 CN CNB028176391A patent/CN100519561C/zh not_active Expired - Lifetime
- 2002-09-06 CN CN200710186668XA patent/CN101172980B/zh not_active Expired - Lifetime
- 2002-09-06 AT AT02797968T patent/ATE453648T1/de active
- 2002-09-06 EA EA200400430A patent/EA010883B1/ru not_active IP Right Cessation
- 2002-09-06 DK DK02797968.1T patent/DK1448567T3/da active
- 2002-09-06 IL IL16016602A patent/IL160166A0/xx unknown
- 2002-09-06 US US10/489,059 patent/US7126015B2/en not_active Expired - Lifetime
- 2002-09-06 SI SI200220026A patent/SI21463B/sl active Search and Examination
- 2002-09-06 KR KR1020047002113A patent/KR100894673B1/ko active IP Right Grant
- 2002-09-06 DE DE60234952T patent/DE60234952D1/de not_active Expired - Lifetime
- 2002-09-06 PL PL367817A patent/PL224030B1/pl unknown
- 2002-09-06 AU AU2002333809A patent/AU2002333809C1/en not_active Expired
- 2002-09-06 AP APAP/P/2004/002981A patent/AP1758A/en active
- 2002-09-06 WO PCT/EP2002/010062 patent/WO2003022853A1/en active IP Right Grant
- 2002-09-06 HU HU0402140A patent/HU229505B1/hu unknown
- 2002-09-06 MX MXPA04002247A patent/MXPA04002247A/es active IP Right Grant
- 2002-09-06 NZ NZ531641A patent/NZ531641A/en not_active IP Right Cessation
- 2002-09-06 CA CA2459168A patent/CA2459168C/en not_active Expired - Lifetime
- 2002-09-09 AR ARP020103403A patent/AR036501A1/es active IP Right Grant
-
2004
- 2004-02-02 IL IL160166A patent/IL160166A/en active IP Right Grant
- 2004-02-24 ZA ZA2004/01501A patent/ZA200401501B/en unknown
- 2004-04-05 HR HRP20040320AA patent/HRP20040320B1/hr not_active IP Right Cessation
- 2004-04-06 NO NO20041434A patent/NO328934B1/no not_active IP Right Cessation
-
2005
- 2005-02-23 HK HK05101515.9A patent/HK1068887A1/xx not_active IP Right Cessation
-
2010
- 2010-03-30 CY CY20101100296T patent/CY1109974T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP1758A (en) | Method for the preparation of hexahydro-furo [2,3-b]furan-3-ol. | |
IL162461A0 (en) | Polymorphs of clopidogrel hydrogensulfate | |
PL371930A1 (en) | Synthesis of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones | |
WO2003074433A8 (es) | Metodo y maquina para la produccion de articulos de vidrio huecos | |
MXPA03010909A (es) | Derivados de epotilona. | |
HK1068299A1 (en) | Method to improve the stability of dispersions of carbon | |
MXPA03008811A (es) | Procedimiento para la preparacion de 4,6-diaminopirimido (5,4-d) pirimidinas. | |
WO2001060981A8 (en) | Tooth progenitor cell and method for its production | |
WO2004004635A3 (en) | Radiolabeled compounds and liposomes and their methods of making and using the same | |
AU2003244727A1 (en) | Novel podophyllotoxin derivatives, the production thereof and the use of the same in therapeutics | |
AU2001277815A1 (en) | Method to determine the quality of eye-optics | |
AU2002239739A1 (en) | Compositions, methods and kits relating to remodelin | |
AU2003302682A1 (en) | Method of increasing neutrophil production using 2,3-benzodiazepines | |
AU2002336564A1 (en) | Method of enzyme production by microorganisms | |
AU2002235773A1 (en) | Yeast strain for testing the geno- and cytotoxicity of complex environmental contamination | |
AU2001278512A1 (en) | Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof | |
HUP0301500A3 (en) | Method for the production of imidazo-(1,2-c)-benzodiazepines and intermediates in the production thereof | |
AU2001232571A1 (en) | Method relating to manufacturing of steel | |
AU2001278703A1 (en) | Process for the production of block copolymers, block copolymers produced by the process, and use of the copolymers | |
IL161800A (en) | Method for the production of desclarithromycin and intermediate products and their use in the production of desclarithromycin | |
AU2002355280A1 (en) | Method to improve the stability of dispersions of carbon | |
GB2415428B (en) | Method to improve the stability of dispersions of carbon | |
AU2002247683A1 (en) | Method for the production of vessels, in particular, culture vessels | |
SG90767A1 (en) | Method of making non-polluting products | |
AU2002325450A1 (en) | Method in the manufacture of steel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |